Global Custom Synthetic Genes Market Growth (Status and Outlook) 2024-2030

Global Custom Synthetic Genes Market Growth (Status and Outlook) 2024-2030

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

The global Custom Synthetic Genes market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Custom Synthetic Genes Industry Forecast” looks at past sales and reviews total world Custom Synthetic Genes sales in 2022, providing a comprehensive analysis by region and market sector of projected Custom Synthetic Genes sales for 2023 through 2029. With Custom Synthetic Genes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Synthetic Genes industry.

This Insight Report provides a comprehensive analysis of the global Custom Synthetic Genes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Synthetic Genes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Synthetic Genes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Synthetic Genes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Synthetic Genes.

United States market for Custom Synthetic Genes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Custom Synthetic Genes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Custom Synthetic Genes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Custom Synthetic Genes players cover Genescript, Thermo Scientific, Twist Bioscience, IDT, DNA 2.0 (ATUM), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Synthetic Genes market by product type, application, key players and key regions and countries.

Segmentation by Type:
Below 1000 bp
1001 - 3000 bp
3001- 5000 bp
Above 5000 bp

Segmentation by Application:
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Below 1000 bp
1001 - 3000 bp
3001- 5000 bp
Above 5000 bp

Segmentation by Application:
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genescript
Thermo Scientific
Twist Bioscience
IDT
DNA 2.0 (ATUM)
OriGene
Eurofins Genomics
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic

Please note: The report will take approximately 2 business days to prepare and deliver.